Original Research
Accepted on 09 Feb 2026
Vitiligo secondary to Immunosuppressants: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
in Immunological Memory
Original Research
Accepted on 09 Feb 2026
in Immunological Memory
Original Research
Accepted on 09 Feb 2026
in Environmental Citizen Science
Correction
Accepted on 09 Feb 2026
in Renal Pharmacology
Original Research
Accepted on 09 Feb 2026
in Public Mental Health
Original Research
Accepted on 09 Feb 2026
in Environmental Economics and Management
Original Research
Accepted on 09 Feb 2026
in Molecular and Cellular Pathology
Original Research
Accepted on 09 Feb 2026
in Neurosurgery
Review
Accepted on 09 Feb 2026
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 09 Feb 2026
in Experimental Pharmacology and Drug Discovery
Brief Research Report
Accepted on 09 Feb 2026
in Psychology of Language
Clinical Trial
Accepted on 09 Feb 2026
in Inflammation Pharmacology
Original Research
Accepted on 09 Feb 2026
in Injury Prevention and Rehabilitation
Original Research
Accepted on 09 Feb 2026
in Respiratory Pharmacology
Original Research
Accepted on 09 Feb 2026
in Health Psychology
Original Research
Accepted on 09 Feb 2026
in Infectious Agents and Disease
Original Research
Accepted on 09 Feb 2026
in Clinical Nutrition